news aktuell GmbH

QUERSUS AND AUDI COMBINE UNIQUE MOTORSPORT DESIGN WITH FUTURISTIC ERGONOMIC CHAIRS

Share
Quersus and Audi unveil their innovative collaboration in 2024 with two ergonomic chairs inspired by Audi's iconic motorsport design. The Quersus VAOS Audi RS Q e-tron and Quersus ICOS Audi chairs combine cutting-edge aesthetics with exceptional comfort, reflecting the performance and technology of Audi's vehicles.
Quersus and Audi unveil their innovative collaboration in 2024 with two ergonomic chairs inspired by Audi's iconic motorsport design. The Quersus VAOS Audi RS Q e-tron and Quersus ICOS Audi chairs combine cutting-edge aesthetics with exceptional comfort, reflecting the performance and technology of Audi's vehicles.

August 30, 2024 – Quersus, one of the leading European ergonomic chair manufacturers, proudly announces an exceptional collaboration with Audi, the renowned German premium car manufacturer. Together, they present two exclusive Quersus models under the Audi license: the Quersus VAOS Audi RS Q e-tron and the Quersus ICOS Audi. These chairs embody the essence of innovation and design, combining superior comfort with cutting-edge automotive aesthetics.


Cutting-Edge Designs inspired by Audi

 

The Quersus VAOS Audi Gaming Chair: Inspired by the design of the Audi RS Q e-tron, victorious in the 2024 Dakar Rally, this gaming chair reflects the spirit of competition and advanced technology. Its bold lines echo the dynamic design of Audi's off-road prototype vehicle.

The Quersus ICOS Audi Office Chair: Inspired by the design of the Audi single-seater study, this ergonomic hybrid office chair with a sporty curve embodies the innovation and pursuit of performance of Audi vehicles. Its modern design, blending sobriety and character, revolutionizes the look of any workspace.


Heading towards the future

The Quersus Audi chairs are made from premium materials, they reflect Audi's quality standards and our commitment to offering extremely durable products, contributing to reducing the frequent renewal of office supplies and minimizing environmental impact. This approach also extends to the packaging, designed with recycled materials.


Exceptional comfort and ergonomics

Quersus chairs provide exceptional support thanks to multiple ergonomic features, such as 4- directional lumbar support, state-of-the-art memory foam, and multiple adjustment options for the backrest and seat. This advanced ergonomic design, the result of years of work and innovation, allows prolonged use without compromising on comfort, enhancing productivity and user health.


More info & photos in the press kit: https://bit.ly/quersusxaudi

Keywords

Contacts

Martin.Steinbach@fleaky.de

Images

The image is to be used exclusively for press releases, promotional materials, and digital platforms related to Quersus and Audi's 2024 collaboration. Any alterations or redistribution without permission is prohibited.
The image is to be used exclusively for press releases, promotional materials, and digital platforms related to Quersus and Audi's 2024 collaboration. Any alterations or redistribution without permission is prohibited.
Download

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

enomyc supports M&A Deal: Multinational AI Alliance Formed to Combat Online Hate27.8.2024 16:43:23 CEST | Press release

Paris / Hamburg, August 27th 2024 – With the acquisition of the Spanish AI specialist Insikt AI by the British company Logically, the M&A experts at the consulting firm enomyc have successfully completed another international transaction. enomyc's Paris office, which led the deal with support from German colleagues, was exclusively commissioned by Insikt AI to find a strategic partner. The acquisition creates a new multinational player in the fight against online hate.

Acousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences12.8.2024 09:00:00 CEST | Press release

Tübingen, Germany, August 12, 2024 Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR clinical study at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston (MA) from August 20–22, and at the 36th World Congress of Audiology from September 19–22, 2024.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye